Early research (Phase 1)UnknownNCT03015922What this trial is testingViral Immunotherapy in Relapsed/Refractory Multiple MyelomaWho this might be right forMultiple Myeloma University of Leeds 4
Testing effectiveness (Phase 2)Ended earlyNCT01555281What this trial is testingNelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple MyelomaWho this might be right forMultiple Myeloma Swiss Cancer Institute 33
Not applicableStudy completedNCT00521430What this trial is testingDonor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Asan Medical Center 30
Large-scale testing (Phase 3)UnknownNCT00002653What this trial is testingCombination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Medical Research Council 1,000
Early research (Phase 1)Study completedNCT00555100What this trial is testingSafety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 15
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT00602706What this trial is testingSamarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell TransplantWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Mayo Clinic 76
Early research (Phase 1)WithdrawnNCT00547404What this trial is testingPhase I Study for Safety and Efficacy of P276-00 in Subjects With MyelomaWho this might be right forMultiple Myeloma Piramal Enterprises Limited 35
Early research (Phase 1)Study completedNCT00079716What this trial is testingStudy of SGN-40 in Patients With Refractory or Recurrent Multiple MyelomaWho this might be right forMultiple Myeloma Seagen Inc. 44
Large-scale testing (Phase 3)Active Not RecruitingNCT00644228What this trial is testingLenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple MyelomaWho this might be right forDS Stage I Multiple MyelomaDS Stage II Multiple MyelomaDS Stage III Multiple Myeloma National Cancer Institute (NCI) 525
Testing effectiveness (Phase 2)Study completedNCT00048412What this trial is testingStem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1HWho this might be right forMyelodysplastic DisordersLeukemiaMultiple Myeloma+2 more Baylor College of Medicine 40
Early research (Phase 1)Study completedNCT00858234What this trial is testingPhase I Study of MK-0683 in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-098)Who this might be right forMultiple Myeloma Merck Sharp & Dohme LLC 9
Early research (Phase 1)Study completedNCT01164709What this trial is testingNelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic CancerWho this might be right forLeukemiaLymphomaMature T-cell and Nk-cell Neoplasms+1 more Swiss Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT00024466What this trial is testingChemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple MyelomaWho this might be right forMultiple Myeloma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 28
Testing effectiveness (Phase 2)Study completedNCT02937571What this trial is testingHigh Dose Carfilzomib for Newly Diagnosed MyelomaWho this might be right forMultiple Myeloma Memorial Sloan Kettering Cancer Center 29
Early research (Phase 1)Study completedNCT00060372What this trial is testingIpilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)UnknownNCT00747877What this trial is testingHigh-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After ChemotherapyWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Leeds Cancer Centre at St. James's University Hospital 460
Early research (Phase 1)Study completedNCT01129193What this trial is testingAR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+64 more Amir Mortazavi 44
Early research (Phase 1)Looking for participantsNCT06375044What this trial is testingStudy of SIM0500 Alone in Participants With Relapsed or Refractory Multiple MyelomaWho this might be right forRelapsed or Refractory Multiple Myeloma Jiangsu Simcere Pharmaceutical Co., Ltd. 130
Very early researchNot Yet RecruitingNCT07234721What this trial is testingSL4903 CAR-T Therapy for Relapsed/Refractory Multiple MyelomaWho this might be right forRelapsed and Refractory Multiple Myeloma (RRMM) Institute of Hematology & Blood Diseases Hospital, China 9